Back to Screener

Healthcare

Johnson & Johnson(JNJ)

Data coverage status ยท 7 need attention

Quote through 2026-08-05T13:30:00Z ยท Stale

Quote synced 2026-08-05T21:40:33.696456Z

Daily bars through 2026-08-03 ยท Stale

Daily bars synced 2026-08-04T22:41:42.67136Z

Fundamentals through 2025-12-31 ยท Stale

Fundamentals synced 2026-08-05T21:39:48.519888Z

Forecasts: Stale

Forecasts synced 2026-04-28T01:48:30.601297Z

Ownership through 2025-12-31 ยท Stale

Ownership synced 2026-08-05T21:39:48.519888Z

Short interest through 2025-12-31 ยท Stale

Short interest synced 2026-08-05T21:39:48.519888Z

News through 2026-05-21T04:31:35Z ยท Stale

News synced 2026-05-21T08:50:04.813249Z

Company profile: Delayed

Company profile synced 2026-05-01T03:44:15.887523Z

Regular-session price

Offline

$257.57($255.00 after-hours, +0.02%)

+1.04% regular session

1Y Change

+49.30%

Window

Aug 5, 2025 โ†’ Aug 4, 2026

Market Cap
$548.73B
P/E
26.5
Trailing
52W Range
$162.78 - $274.90
Volume
4.30M
0.5x RVOL

Investment Snapshot

Valuation, growth, profitability, catalysts, and benchmark context.

Quote + TTM fundamentalsForecast

1D

+1.0%

1M

-1.7%

6M

+8.7%

YTD

+22.9%

1Y

+49.3%

Coverage: 250 bars ยท Aug 5, 2025 โ†’ Aug 4, 2026

Benchmark Edge

JNJ vs SPY, QQQ, and Sector ETFs

Normalized return, excess return, max drawdown, and calendar-year wins against the benchmarks investors actually use.

Shared 1Y chart + MAX history table

Relative Read

Mixed setup vs SPY

JNJ is 26.47 pts ahead over the shared 1Y window.

JNJ had 1.83 pts deeper max drawdown than SPY.

JNJ beat SPY in 2 of 2 calendar years shown and trailed in 0.

JNJ

+49.30%

Normalized return

SPY

+22.83%

S&P 500

Excess Return

+26.47 pts

Relative to SPY

JNJ Max Drawdown

-10.96%

Trailing 1Y

SPY Max Drawdown

-9.13%

Trailing 1Y

JNJSPY

Calendar-Year Returns

Uses the longest available daily history for JNJ and SPY.

YearJNJSPYExcessLeader
2026+22.94%+12.67%+10.27 ptsJNJ
2025+21.18%+9.40%+11.78 ptsJNJ

Earnings Reports

Next earnings reportOct 15, 2026
PeriodB/MEPSEPS ฮ”RevenueRev ฮ”Report
Q3
Jul 15, 26
โœ“
2.90
Est 2.85
+1.8%
โ€”
Est โ€”
โ€”
Jul 15
Q2
Apr 14, 26
โœ“
2.70
Est 2.68
+0.7%
โ€”
Est โ€”
โ€”
Apr 14
Q1
Jan 21, 26
โ€”
2.46
Est 2.46
0.0%
โ€”
Est โ€”
โ€”
Jan 21
Q4
Dec 9, 25
โœ“
0.38
Est 0.18
+111.1%
โ€”
Est โ€”
โ€”
Dec 9
No upcoming earnings in the next 90 days

Next Step

Connect reports to catalysts

Earnings pages get much more useful when they are tied back to upcoming dates, expectations, and peer setups.